Following further evaluation, MenSCs increased the survival of xenograft-versus-host disease (GVHD) in mice/rats by limiting the proliferation of CD4 + IFN-γ + or CD8 + IFN-γ + T cells that exert an immunosuppressive function [54]. The gene discussed is CD8A; the disease is graft versus host disease.